Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

amphethinile

Known as: 2-amino-3-cyano-5-(phenylthio)indole 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1992
Review
1992
The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: critical evaluation and recommendations for future studies.
Phase I studies requiring multiple dose escalation steps have led to the development of pharmacokinetically guided dose… Expand
Highly Cited
1989
Highly Cited
1989
Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile.
The novel agents amphethinile and combretastatin A4 are shown to be very similar to colchicine in their interactions with… Expand
1989
1989
Interaction of the novel agent amphethinile with tubulin.
The novel agent amphethinile is shown to inhibit tubulin assembly in vitro. This agent is capable of displacing colchicine but… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
1988
1988
A phase I and pharmacokinetic study of amphethinile.
Amphethinile is a new spindle poison with a novel structure that has shown activity in the L1210, ADJ/PC6 and Walker carcinoma… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
1988
1988
Pre-clinical studies of a novel anti-mitotic agent, amphethinile.
A new antitumour agent is described, which has been shown to induce a G2/M block in murine leukaemia cells in vitro. In addition… Expand
  • figure 1
  • table I
  • table II
  • figure 2
  • table III
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE